Progress in the Treatment of Myelodysplastic Syndromes (MDS)

Listen Now

Topics Covered

• Overview of Myelodysplastic Syndromes (MDS), in the Context of COVID-19
• Diagnosis & Staging
• Current Standard of Care
• New & Emerging Treatment Approaches
• The Role of Clinical Trials
• Tips to Manage Symptoms, Side Effects & Discomfort
• Nutrition & Hydration Concerns & Tips
• Key Questions to Ask Your Health Care Team during Telehealth Appointments
• Guidelines to Prepare for Telehealth Appointments including Technology & List of Questions
• Next Step After Treatment - Follow-Up Care
• Questions for Our Panel of Experts

Our Panel of Experts

Ruben A. Mesa, MD, FACP

Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, UT Health San Antonio Cancer Center – An NCI Designated Cancer Center

Rami Komrokji, MD

Senior Member & Professor of Oncologic Sciences, Section Head – Leukemia and MDS, Vice Chair – Malignant Hematology Department, Moffitt Cancer Center

Diana L. Bearden, MS, RD, CSO, LD, CNSC

Oncology Dietitian, Michael E. DeBakey VA Medical Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on May 03, 2021.